Login to Your Account



Pharma: Other News To Note


Friday, September 6, 2013
Endo Pharmaceuticals Inc., of Malvern, Pa., said the FDA accepted a complete response submission for Aveed, a long-acting testosterone undecanoate injection, for hypogonadism in men.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription